A phase II study of gemcitabine, oxaliplatin, and erlotinib (GEMOX-T) combination chemotherapy in previously untreated patients with locally advanced unresectable or metastatic pancreatic cancer
- All Author(s)
- J. Yun
; H. J. Kim
; K. H. Kim
; S. H. Kim
; S.-C. Lee
; S. B. Bae
; C. K. Kim
; N. Lee
; K. T. Lee
; S. K. Park
; J.-H. Won
; D. S. Hong
; H. S. Park
; H. J. Choi
; J. H. Moon
- Intsitutional Author(s)
- 김한조; 이상철; 배상병; 이규택
- Issued Date
- 2014
- Type
- Conference
- Conference Name
- 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
- Conference Date
- 41789
- dc_citation_conferenceCountry
- Chicago, IL, United States
- Citation Publisher
- American Society of Clinical Oncology
- Citation Title
- Journal of Clinical Oncology. Volume 32, Number 15_suppl
- Citation Start Page
- e15260
- Citation End Page
- e15260
- Language(ISO)
- eng
- DOI
- 10.1200/jco.2014.32.15_suppl.e15260
- URI
- http://schca-ir.schmc.ac.kr/handle/2022.oak/4534
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.